Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone in acquired brain injury
NCT03273062Phase 2Unknown
- Sponsor
- Sheppard Pratt
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tolcapone in acquired brain injury (ABI) and traumatic brain injury (TBI) (2 arms), sponsored by Sheppard Pratt. Primary endpoint: NIH Toolbox Fluid Cognitive Battery at 14 days. Status: unknown.
02
Drugs
tolcapone
03
Conditions
acquired brain injury (ABI)traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT03273062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03273062.